Endeavour Vision is an investment firm focused on transformative healthcare technologies.
We are one of the world’s largest and most experienced investment firms focused on medical devices and digital health. Our team of entrepreneurs, scientists, and investment experts has helped to shape and grow portfolio companies on both sides of the Atlantic into global leaders.
We focus on companies that endeavour to solve the most pressing unmet needs in health. We empower entrepreneurs to develop and commercialise technologies that can modernise healthcare systems and advance patient care.
Latest Endeavour Vision News
Portfolio Companies
Testimonials
“From our introductory meeting, through the diligence and investment process and now as an active board member, the Endeavour Vision team has been a great partner. The team brings deep insights and a pragmatic approach to assisting high growth companies across a broad array of disciplines. Moreover, the team is a pleasure to work with and we look forward to our great partnership with Endeavour Vision as we continue to grow globally.”
Robert Spignesi, CEO, Rapid Micro Biosystems“We find in Endeavour Vision a unique and highly-sophisticated team, which adds significant value to our commercialization ramp-up. This includes strategic input, organisational development and talent acquisition. They’re a team which works closely with management to identify creative solutions to complex issues, leading the maximum value creation for the enterprise. I highly recommend Endeavour Vision as a valuable venture partner.”
Earl R. Fender, Previously President & CEO, Vertiflex“As the founding investor in CeQur, Endeavour Vision has been an invaluable partner over the years, providing strategic input, on-going support and financing. I’ve enjoyed getting to know several members of the team, each bringing their own unique expertise, and all committed to our success. In the world of healthcare technology, you’d be hard pressed to find a better partner.”
Bradley Paddock, CEO, CeQur Corporation“Endeavour Vision is an extremely thorough and thoughtful healthcare investor, and at Virtual Incision we sincerely value and appreciate their Series C support. EV brings domain knowledge and a global perspective to help us pioneer the use of mini-robots for abdominal procedures — great partners to have around our board table.”
John Murphy, CEO, Virtual Incision Corporation“Miach Orthopaedics is proud to partner with Endeavour Vision and is thrilled with the team’s positive impact on our organization. Right from the start of their Series B due diligence, Endeavour proved a value-added partner. Their thorough preparation, understanding of our sports medicine business, and shared insights into early commercialization challenges enhanced our business plan. Post-investment, Endeavour’s keen sense of strategy and tactics has facilitated our successful commercial introduction.”
Patrick A. McBrayer, President & CEO, Miach Orthopaedics“Endeavour Vision has been a dedicated and trusted partner in our journey to transform the diagnosis and treatment of vertebrogenic pain. The Endeavor Vision team has provided meaningful strategic insights as we evolved from our initial market launch, securing our CPT I code and full commercialization. We look forward to EV’s continued partnership and contributions as we accelerate our commercial efforts and prepare for the public market.”
Tyler Binney, CEO, Relievant